EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial

Thitiya Lukkunaprasit, Patompong Satapornpong, Pongsiri Kulchanawichien, Abhisit Prawang, Chaiwat Limprasert, Worawan Saingam, Chatpetch Permsombut, Wongvarit Panidthananon, Arthimond Vutthipong, Yupin Lawanprasert, Parnthep Pourpongpan, Supakit Wongwiwatthananukit und 2 weitere

Complementary Therapies in Medicine · 2024

DOI: 10.1016/j.ctim.2024.103107 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Complementary Therapies in Medicine, 2024. Verfasst von Thitiya Lukkunaprasit und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Administration, College of Pharmacy, Rangsit University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Plant Extracts, Quality of Life, COVID-19 Drug Treatment, C-Reactive Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Long COVID have posed a global health burden since the COVID-19 pandemic. This study aimed to evaluate the efficacy and safety of a combined plant extract (CPE) formulation, containing Citrus aurantifolia, Tiliacora triandra, Cannabis sativa, Alpinia galanga, and Piper nigrum, in participants with long COVID. A newly developed long COVID symptom questionnaire was used to evaluate outcomes. METHODS: This randomized, double-blinded, placebo-controlled trial was conducted at the College of Pharmacy, Rangsit University, Thailand. Participants were randomly assigned to receive either a CPE supplement (4500 mg/day) or a placebo for 7 days. Primary outcomes were changes in C-reactive protein (CRP) levels and the total symptom score (ranging from 0 to 57 points). Secondary outcomes included full recovery/improvement of long COVID symptoms, health-related quality of life (HRQOL), and adverse events. RESULTS: A total of 66 participants were enrolled, with 33 in each group. The CPE supplement did not significantly reduce CRP levels, with a median difference (MD) (95 % CI) of -0.05 (-0.49, 0.39) mg/L compared to placebo. However, the CPE group showed a reduction in the total symptom score [MD (95 % CI) of -4.00 (-7.58, -0.42)], and a reduction in overall moderate to severe symptoms [RR (95 % CI) of 0.57 (0.35, 0.91)], moderate to severe fatigue [RR (95 % CI) of 0.25 (0.08, 0.81)], and moderate to severe post-exertional malaise (PEM) [RR (95 % CI) of 0.35 (0.16, 0.78)]. Changes in HRQOL scores did not differ significantly between groups. Adverse events were mostly mild and resolved by the end of the follow-up period. CONCLUSIONS: Our study suggests potential benefits of the CPE in alleviating moderate to severe long COVID symptoms, particularly fatigue and PEM, with an acceptable safety profile. However, larger-scale trials are necessary to validate these findings, and assessing the reliability of the long COVID symptom questionnaire is essential before its application in future studies. TRIAL REGISTRATION NUMBER: TCTR20230131004 (Registration date: 2023-01-31, Thai Clinical Trials Registry).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsQuality of LifeCOVID-19 Drug TreatmentC-Reactive ProteinHumansMaleFemaleMiddle AgedDouble-Blind MethodAdultThailandCOVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeAlpiniaPiper nigrumCitrusAgedPhytotherapy

Stichwörter der Autor:innen

Alpinia galangaCannabis sativaCitrus aurantifoliaCombined plant extractFatigueHerbal supplementLong COVIDPiper nigrumPost-COVIDPost-exertional malaiseTiliacora triandra

Substanzen

Plant ExtractsC-Reactive Protein

Autor:innen und Institutionen

  • Department of Pharmacy Administration, College of Pharmacy, Rangsit University, Pathum Thani, Thailand.
  • Division of General Pharmacy Practice, Department of Pharmaceutical Care, College of Pharmacy, Rangsit University, Pathum Thani, Thailand; Excellence Pharmacogenomics and Precision Medicine Centre, College of Pharmacy,…
  • Division of Pharmacy Practice, Department of Pharmaceutical Care, College of Pharmacy, Rangsit University, Pathum Thani, Thailand.
  • Drug and Herbal Product Research and Development Center, College of Pharmacy, Rangsit University, Pathum Thani, Thailand.
  • MW Wellness Health Center, Bangkok, Thailand.
  • Department of Pharmacognosy, College of Pharmacy, Rangsit University, Pathum Thani, Thailand.

Zitieren

APA

Lukkunaprasit, T., Satapornpong, P., Kulchanawichien, P., Prawang, A., Limprasert, C., Saingam, W., Permsombut, C., Panidthananon, W., Vutthipong, A., Lawanprasert, Y., Pourpongpan, P., Wongwiwatthananukit, S., Songsak, T., & Pradubyat, N. (2024). Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial. Complementary Therapies in Medicine. https://doi.org/10.1016/j.ctim.2024.103107

Vancouver

Lukkunaprasit T, Satapornpong P, Kulchanawichien P, Prawang A, Limprasert C, Saingam W, et al. Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial. Complementary Therapies in Medicine. 2024. doi:10.1016/j.ctim.2024.103107

BibTeX
@article{Lukkunaprasit2024,
  author = {Lukkunaprasit, Thitiya and Satapornpong, Patompong and Kulchanawichien, Pongsiri and Prawang, Abhisit and Limprasert, Chaiwat and Saingam, Worawan and Permsombut, Chatpetch and Panidthananon, Wongvarit and Vutthipong, Arthimond and Lawanprasert, Yupin and Pourpongpan, Parnthep and Wongwiwatthananukit, Supakit and Songsak, Thanapat and Pradubyat, Nalinee},
  title = {Impact of combined plant extracts on long COVID: An exploratory randomized controlled trial},
  journal = {Complementary Therapies in Medicine},
  year = {2024},
  doi = {10.1016/j.ctim.2024.103107}
}
Kostenlos starten →